» Articles » PMID: 38464668

Engineering Models of Head and Neck and Oral Cancers On-a-chip

Abstract

Head and neck cancers (HNCs) rank as the sixth most common cancer globally and result in over 450 000 deaths annually. Despite considerable advancements in diagnostics and treatment, the 5-year survival rate for most types of HNCs remains below 50%. Poor prognoses are often attributed to tumor heterogeneity, drug resistance, and immunosuppression. These characteristics are difficult to replicate using or models, culminating in few effective approaches for early detection and therapeutic drug development. Organs-on-a-chip offer a promising avenue for studying HNCs, serving as microphysiological models that closely recapitulate the complexities of biological tissues within highly controllable microfluidic platforms. Such systems have gained interest as advanced experimental tools to investigate human pathophysiology and assess therapeutic efficacy, providing a deeper understanding of cancer pathophysiology. This review outlines current challenges and opportunities in replicating HNCs within microphysiological systems, focusing on mimicking the soft, glandular, and hard tissues of the head and neck. We further delve into the major applications of organ-on-a-chip models for HNCs, including fundamental research, drug discovery, translational approaches, and personalized medicine. This review emphasizes the integration of organs-on-a-chip into the repertoire of biological model systems available to researchers. This integration enables the exploration of unique aspects of HNCs, thereby accelerating discoveries with the potential to improve outcomes for HNC patients.

Citing Articles

Advances in modeling periodontal host-microbe interactions: insights from organotypic and organ-on-chip systems.

Makkar H, Sriram G Lab Chip. 2025; 25(5):1342-1371.

PMID: 39963082 PMC: 11833442. DOI: 10.1039/d4lc00871e.


Microfluidic organ-on-chip systems for periodontal research: advances and future directions.

Sriram G, Makkar H Front Bioeng Biotechnol. 2025; 12:1490453.

PMID: 39840127 PMC: 11747509. DOI: 10.3389/fbioe.2024.1490453.


Development and Characterization of a Three-Dimensional Organotypic In Vitro Oral Cancer Model with Four Co-Cultured Cell Types, Including Patient-Derived Cancer-Associated Fibroblasts.

Aizawa Y, Haga K, Yoshiba N, Yortchan W, Takada S, Tanaka R Biomedicines. 2024; 12(10).

PMID: 39457685 PMC: 11505046. DOI: 10.3390/biomedicines12102373.

References
1.
Engelmann L, Thierauf J, Laureano N, Stark H, Prigge E, Horn D . Organotypic Co-Cultures as a Novel 3D Model for Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2020; 12(8). PMC: 7463661. DOI: 10.3390/cancers12082330. View

2.
Gormley M, Creaney G, Schache A, Ingarfield K, Conway D . Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022; 233(9):780-786. PMC: 9652141. DOI: 10.1038/s41415-022-5166-x. View

3.
Bhat G, Hyole R, Li J . Head and neck cancer: Current challenges and future perspectives. Adv Cancer Res. 2021; 152:67-102. DOI: 10.1016/bs.acr.2021.05.002. View

4.
Foglizzo V, Cocco E, Marchio S . Advanced Cellular Models for Preclinical Drug Testing: From 2D Cultures to Organ-on-a-Chip Technology. Cancers (Basel). 2022; 14(15). PMC: 9367322. DOI: 10.3390/cancers14153692. View

5.
Ingber D . Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies?. Adv Sci (Weinh). 2020; 7(22):2002030. PMC: 7675190. DOI: 10.1002/advs.202002030. View